Cough-generated Aerosols of Pseudomonas aeruginosa and other Bacteria from Cystic Fibrosis Patients.

Department of Respiratory Medicine, Royal Children's Hospital and Health Service District, Brisbane, Australia.
Thorax (Impact Factor: 8.29). 08/2009; 64(11):926-31. DOI: 10.1136/thx.2008.112466
Source: PubMed


Pseudomonas aeruginosa is the most common bacterial pathogen in patients with cystic fibrosis (CF). Current infection control guidelines aim to prevent transmission via contact and respiratory droplet routes and do not consider the possibility of airborne transmission. It was hypothesised that subjects with CF produce viable respirable bacterial aerosols with coughing.
A cross-sectional study was undertaken of 15 children and 13 adults with CF, 26 chronically infected with P aeruginosa. A cough aerosol sampling system enabled fractioning of respiratory particles of different sizes and culture of viable Gram-negative non-fermentative bacteria. Cough aerosols were collected during 5 min of voluntary coughing and during a sputum induction procedure when tolerated. Standardised quantitative culture and genotyping techniques were used.
P aeruginosa was isolated in cough aerosols of 25 subjects (89%), 22 of whom produced sputum samples. P aeruginosa from sputum and paired cough aerosols were indistinguishable by molecular typing. In four cases the same genotype was isolated from ambient room air. Approximately 70% of viable aerosols collected during voluntary coughing were of particles <or=3.3 microm aerodynamic diameter. P aeruginosa, Burkholderia cenocepacia, Stenotrophomonas maltophilia and Achromobacter xylosoxidans were cultivated from respiratory particles in this size range. Positive room air samples were associated with high total counts in cough aerosols (p = 0.003). The magnitude of cough aerosols was associated with higher forced expiratory volume in 1 s (r = 0.45, p = 0.02) and higher quantitative sputum culture results (r = 0.58, p = 0.008).
During coughing, patients with CF produce viable aerosols of P aeruginosa and other Gram-negative bacteria of respirable size range, suggesting the potential for airborne transmission.

Download full-text


Available from: Claire Wainwright,
  • Source
    • "By studying the aerosols produced by infected individuals, we hope to precisely characterize how long virus infectivity persists in suspended aerosol droplets of various sizes. Recent work has begun to address this question for bacterial transmission by patients with cystic fibrosis [8, 9]. The question of droplet survival duration pertains to droplet size distribution and, on this front, there are discrepancies across the literature which are likely due to the varying measurement methodologies and techniques. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Influenza virus is responsible for annual deaths due to seasonal epidemics and is the cause of major pandemics which have claimed millions of human lives over the last century. Knowledge about respiratory virus transmission is advancing. Spread is likely through the air, but much work remains to be done to characterize the aerosols produced by infected individuals, including viral particle survival and infectivity. Although coughs have been characterized, little work has been done to examine coughs from infected individuals. The WeCoF project aims at providing evidence to support prevention measures to mitigate person-to-person influenza transmission in critical locations, such as hospitals, and during pandemics. Findings: A novel experimental cough chamber facility - the FLUGIE - has been developed to study the far-field aerodynamics and aerosol transport of droplets produced by the coughs from humans naturally-infected with influenza. The flow field of each cough is measured using Particle Image Velocimetry (PIV). A preliminary study involving 12 healthy individuals has been carried out in order to quantify the strengths of their coughs at a distance of 1 m from the mouth. The spatially averaged maximum velocity was determined and the average value was 0.41 m/s across 27 coughs of good data quality. The peak value of velocity was also extracted and compared with the average velocity. Conclusions: Preliminary results show that there is significant air motion associated with a cough (on the order of 0.5 m/s) as far away as 1 m from the mouth of the healthy person who coughs. The results from this pilot study provide the framework for a more extensive participant recruitment campaign that will encompass a statistically-significant cohort.
    BMC Research Notes 08/2014; 7(1):563. DOI:10.1186/1756-0500-7-563
  • Source
    • "Curtains have been found to be contaminated with bacteria such as Acinetobacter [17] and have been shown to release S. aureus upon vigorous movement [11]. Other specific bacteria to be sampled from the air include Pseudomonas aeruginosa and Burkholderia cepacia which have been shown to be released in to the air on respirable sized particles [18] from patients coughing as well as after nebuliser use [19]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Transport of infectious particles through the air has the potential to contaminate the indoor environment creating reservoirs of infectious material on surfaces. There is evidence that typical nursing activities can release large quantities of bacteria including MRSA into the hospital air, which may lead to surface contamination thereby increasing opportunities for further spread. Air sampling studies were conducted over a period of 5 days on a four-bed bay in a respiratory ward. Results showed that sampled bioaerosols are more likely to be carried on large particles >5 µm in diameter, and that the relationship between bioaerosols and particle size varies when respiratory interventions are in use. Increased activity in the hospital bay was shown to correlate to increased concentrations of bioaerosols whereas sedentary visitors did not. In particular, the occurrence of patient washing that occurred behind closed curtains correlated to large values of bioaerosol release. Floor cleaning generated large number of particles, but with no significant increase in sampled bioaerosols. This provides valuable information for understanding when and where bioaerosols are released on a hospital ward which may inform future research into physical segregation of patients and the definition of bioaerosol sources in computer simulations.
    Indoor and Built Environment 04/2013; 22(2):410-21. DOI:10.1177/1420326X11428088 · 1.23 Impact Factor
  • Source
    • "Such strains have been found in the United Kingdom and Europe (Manchester epidemic strain [MA], Liverpool epidemic strain [LES] [10,11] and Clone C [12]), as well as Canada [13] and Australia (Australian epidemic strain 1 [AES-1] [7]). Increasing evidence suggests that transmission between patients occurs via a cough-associated aerosol route [14,15]. The majority of epidemic strains display evidence of increased virulence in CF patients [16] and transmission to patients with non-CF bronchiectasis, or even otherwise healthy relatives, has been detected [17]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Pseudomonas aeruginosa is an opportunistic pathogen that is the major cause of morbidity and mortality in patients with cystic fibrosis (CF). While most CF patients are thought to acquire P. aeruginosa from the environment, person-person transmissible strains have been identified in CF clinics worldwide. The molecular basis for transmissibility and colonization of the CF lung remains poorly understood. A dual proteomics approach consisting of gel-based and gel-free comparisons were undertaken to analyse protein profiles in a transmissible, early (acute) isolate of the Australian epidemic strain 1 (AES-1R), the virulent burns/wound isolate PA14, and the poorly virulent, laboratory-associated strain PAO1. Over 1700 P. aeruginosa proteins were confidently identified. AES-1R protein profiles revealed elevated abundance of proteins associated with virulence and siderophore biosynthesis and acquisition, antibiotic resistance and lipopolysaccharide and fatty acid biosynthesis. The most abundant protein in AES-1R was confirmed as a previously hypothetical protein with sequence similarity to carbohydrate-binding proteins and database search revealed this gene is only found in the CF-associated strain PA2192. The link with CF infection may suggest that transmissible strains have acquired an ability to rapidly interact with host mucosal glycoproteins. Our data suggest that AES-1R expresses higher levels of proteins, such as those involved in antibiotic resistance, iron acquisition and virulence that may provide a competitive advantage during early infection in the CF lung. Identification of novel proteins associated with transmissibility and acute infection may aid in deciphering new strategies for intervention to limit P. aeruginosa infections in CF patients.
    BMC Microbiology 01/2012; 12(1):16. DOI:10.1186/1471-2180-12-16 · 2.73 Impact Factor
Show more